![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 48/00 | (2006.01) |
A61K 31/713 | (2006.01) | ||
C12N 15/11 | (2006.01) | ||
C07H 21/00 | (2006.01) | ||
A61P 35/04 | (2006.01) | ||
C12N 15/113 | (2010.01) |
(11) | Patento numeris | 2399611 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 10181204.8 |
Europos patento paraiškos padavimo data | 2005-02-28 | |
(97) | Europos patento paraiškos paskelbimo data | 2011-12-28 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2017-06-14 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
558135 P | 2004-04-01 | US | |
04004478 | 2004-02-27 | EP |
(72) |
Schlingensiepen, Karl-Hermann, Dr., DE
Schlingensiepen, Reimar, Dr., DE
Jachimczak, Piotr, Dr., DE
Hafner, Michael, Dr., DE
Bischof, Astrid, Dr., DE
Bauer, Tamara, Dr. (geboren Egger), CH
Stauder, Gerhard, Dr., DE
|
(73) |
Autotelic LLC,
17870 Castleton Street, Suite 250, City of Industry, CA 91748,
US
|
(54) | USE OF AN OLIGONUCLEOTIDE OR ITS ACTIVE DERIVATIVE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR INHIBITING THE FORMATON OF METASATASES IN CANCER TREATMENT |
USE OF AN OLIGONUCLEOTIDE OR ITS ACTIVE DERIVATIVE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR INHIBITING THE FORMATON OF METASATASES IN CANCER TREATMENT |